Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
To determine long-term safety and efficacy of pregabalin in patients with partial seizures.
Inclusion Criteria:
Exclusion Criteria:
Chastwood, New South Wales 2067, Australia
Auenbruggerplatz 22, A-8035 GRAZ, Austria
AE Breda, 4836, Netherlands
Ve Heeze, 5591, Netherlands